{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:17:40Z","timestamp":1794021460761,"version":"4.8.0"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41584-020-0469-2","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T11:06:10Z","timestamp":1597662370000},"page":"547-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Fibroblast growth factor signalling in osteoarthritis and cartilage repair"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-1126","authenticated-orcid":false,"given":"Yangli","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Zinkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-9412","authenticated-orcid":false,"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moosa","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"469_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1126\/science.1222454","volume":"338","author":"DJ Huey","year":"2012","unstructured":"Huey, D. J., Hu, J. C. & Athanasiou, K. A. Unlike bone, cartilage regeneration remains elusive. Science 338, 917\u2013921 (2012).","journal-title":"Science"},{"key":"469_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","volume":"26","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. & Jordan, J. M. Epidemiology of osteoarthritis. Clin. Geriatr. Med. 26, 355\u2013369 (2010).","journal-title":"Clin. Geriatr. Med."},{"key":"469_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/BOR.0000000000000161","volume":"27","author":"KD Allen","year":"2015","unstructured":"Allen, K. D. & Golightly, Y. M. State of the evidence. Curr. Opin. Rheumatol. 27, 276\u2013283 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"469_CR4","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.1073\/pnas.1703856114","volume":"114","author":"IJ Wallace","year":"2017","unstructured":"Wallace, I. J. et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc. Natl Acad. Sci. USA 114, 9332\u20139336 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","volume":"2","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier, J. et al. Osteoarthritis. Nat. Rev. Dis. Prim. 2, 16072 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"469_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1136\/ard.2011.150243","volume":"70","author":"FW Roemer","year":"2011","unstructured":"Roemer, F. W. et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann. Rheum. Dis. 70, 1804\u20131809 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","volume":"11","author":"R Liu-Bryan","year":"2015","unstructured":"Liu-Bryan, R. & Terkeltaub, R. Emerging regulators of the inflammatory process in osteoarthritis. Nat. Rev. Rheumatol. 11, 35\u201344 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745\u20131759 (2019).","journal-title":"Lancet"},{"key":"469_CR9","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma, J. W., Berenbaum, F. & Lafeber, F. P. Osteoarthritis: an update with relevance for clinical practice. Lancet 377, 2115\u20132126 (2011).","journal-title":"Lancet"},{"key":"469_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41584-019-0255-1","volume":"15","author":"H Kwon","year":"2019","unstructured":"Kwon, H. et al. Surgical and tissue engineering strategies for articular cartilage and meniscus repair. Nat. Rev. Rheumatol. 15, 550\u2013570 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/1759720X15576866","volume":"7","author":"ML Tiku","year":"2015","unstructured":"Tiku, M. L. & Sabaawy, H. E. Cartilage regeneration for treatment of osteoarthritis: a paradigm for nonsurgical intervention. Ther. Adv. Musculoskelet. Dis. 7, 76\u201387 (2015).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"469_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrrheum.2013.29","volume":"9","author":"SC Mastbergen","year":"2013","unstructured":"Mastbergen, S. C., Saris, D. B. & Lafeber, F. P. Functional articular cartilage repair: here, near, or is the best approach not yet clear? Nat. Rev. Rheumatol. 9, 277\u2013290 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s00018-019-03191-5","volume":"76","author":"R Chijimatsu","year":"2019","unstructured":"Chijimatsu, R. & Saito, T. Mechanisms of synovial joint and articular cartilage development. Cell. Mol. Life Sci. 76, 3939\u20133952 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.24418","volume":"114","author":"MB Ellman","year":"2013","unstructured":"Ellman, M. B. et al. Fibroblast growth factor control of cartilage homeostasis. J. Cell. Biochem. 114, 735\u2013742 (2013).","journal-title":"J. Cell. Biochem."},{"key":"469_CR15","doi-asserted-by":"publisher","first-page":"14003","DOI":"10.1038\/boneres.2014.3","volume":"2","author":"N Su","year":"2014","unstructured":"Su, N., Jin, M. & Chen, L. Role of FGF\/FGFR signaling in skeletal development and homeostasis: learning from mouse models. Bone Res. 2, 14003 (2014).","journal-title":"Bone Res."},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1101\/gad.266551.115","volume":"29","author":"DM Ornitz","year":"2015","unstructured":"Ornitz, D. M. & Marie, P. J. Fibroblast growth factor signaling in skeletal development and disease. Genes Dev. 29, 1463\u20131486 (2015).","journal-title":"Genes Dev."},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug. Discov. 8, 235\u2013253 (2009).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jb\/mvq121","volume":"149","author":"N Itoh","year":"2011","unstructured":"Itoh, N. & Ornitz, D. M. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J. Biochem. 149, 121\u2013130 (2011).","journal-title":"J. Biochem."},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz, R. et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell Biol. 27, 3417\u20133428 (2007).","journal-title":"Mol. Cell Biol."},{"key":"469_CR20","doi-asserted-by":"publisher","first-page":"a015958","DOI":"10.1101\/cshperspect.a015958","volume":"5","author":"AA Belov","year":"2013","unstructured":"Belov, A. A. & Mohammadi, M. Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology. Cold Spring Harb. Perspect. Biol. 5, a015958 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"469_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","volume":"98","author":"AN Plotnikov","year":"1999","unstructured":"Plotnikov, A. N., Schlessinger, J., Hubbard, S. R. & Mohammadi, M. Structural basis for FGF receptor dimerization and activation. Cell 98, 641\u2013650 (1999).","journal-title":"Cell"},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","volume":"16","author":"M Mohammadi","year":"2005","unstructured":"Mohammadi, M., Olsen, S. K. & Ibrahimi, O. A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107\u2013137 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1073\/pnas.97.1.49","volume":"97","author":"DJ Stauber","year":"2000","unstructured":"Stauber, D. J., DiGabriele, A. D. & Hendrickson, W. A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA 97, 49\u201354 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.str.2011.10.022","volume":"20","author":"J Kalinina","year":"2012","unstructured":"Kalinina, J. et al. The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition. Structure 20, 77\u201388 (2012).","journal-title":"Structure"},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1073\/pnas.0307287101","volume":"101","author":"SK Olsen","year":"2004","unstructured":"Olsen, S. K. et al. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc. Natl Acad. Sci. USA 101, 935\u2013940 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.bi.62.070193.002321","volume":"62","author":"WJ Fantl","year":"1993","unstructured":"Fantl, W. J., Johnson, D. E. & Williams, L. T. Signalling by receptor tyrosine kinases. Annu. Rev. Biochem. 62, 453\u2013481 (1993).","journal-title":"Annu. Rev. Biochem."},{"key":"469_CR27","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1096\/fasebj.6.15.1464370","volume":"6","author":"D Givol","year":"1992","unstructured":"Givol, D. & Yayon, A. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J. 6, 3362\u20133369 (1992).","journal-title":"FASEB J."},{"key":"469_CR28","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1074\/jbc.271.25.15292","volume":"271","author":"DM Ornitz","year":"1996","unstructured":"Ornitz, D. M. et al. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292\u201315297 (1996).","journal-title":"J. Biol. Chem."},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694\u201315700 (2006).","journal-title":"J. Biol. Chem."},{"key":"469_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","volume":"6","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger, J. et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743\u2013750 (2000).","journal-title":"Mol. Cell"},{"key":"469_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbagen.2008.09.001","volume":"1790","author":"M Asada","year":"2009","unstructured":"Asada, M. et al. Glycosaminoglycan affinity of the complete fibroblast growth factor family. Biochim. Biophys. Acta 1790, 40\u201348 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"469_CR32","doi-asserted-by":"publisher","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","volume":"3","author":"S Sarrazin","year":"2011","unstructured":"Sarrazin, S., Lamanna, W. C. & Esko, J. D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3, a004952 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"469_CR33","doi-asserted-by":"publisher","first-page":"29134","DOI":"10.1074\/jbc.M112.342980","volume":"287","author":"R Goetz","year":"2012","unstructured":"Goetz, R. et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. J. Biol. Chem. 287, 29134\u201329146 (2012).","journal-title":"J. Biol. Chem."},{"key":"469_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrm3528","volume":"14","author":"R Goetz","year":"2013","unstructured":"Goetz, R. & Mohammadi, M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol. 14, 166\u2013180 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"469_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fendo.2015.00154","volume":"6","author":"N Itoh","year":"2015","unstructured":"Itoh, N., Ohta, H. & Konishi, M. Endocrine FGFs: evolution, physiology, pathophysiology, and pharmacotherapy. Front. Endocrinol. 6, 154 (2015).","journal-title":"Front. Endocrinol."},{"key":"469_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4614-0887-1_1","volume":"728","author":"A Beenken","year":"2012","unstructured":"Beenken, A. & Mohammadi, M. The structural biology of the FGF19 subfamily. Adv. Exp. Med. Biol. 728, 1\u201324 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"469_CR37","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu, H. et al. Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120\u20136123 (2006).","journal-title":"J. Biol. Chem."},{"key":"469_CR38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770\u2013774 (2006).","journal-title":"Nature"},{"key":"469_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz, R. et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-klotho complex formation. Proc. Natl Acad. Sci. USA 107, 407\u2013412 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0959-440X(97)80072-3","volume":"7","author":"B Henrissat","year":"1997","unstructured":"Henrissat, B. & Davies, G. Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637\u2013644 (1997).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"469_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature25451","volume":"553","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. \u03b1-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature 553, 461\u2013466 (2018).","journal-title":"Nature"},{"key":"469_CR42","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0701600104","volume":"104","author":"Y Ogawa","year":"2007","unstructured":"Ogawa, Y. et al. \u03b2Klotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl Acad. Sci. USA 104, 7432\u20137437 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR43","doi-asserted-by":"publisher","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu, H. et al. Tissue-specific expression of \u03b2klotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687\u201326695 (2007).","journal-title":"J. Biol. Chem."},{"key":"469_CR44","doi-asserted-by":"publisher","first-page":"ra55","DOI":"10.1126\/scisignal.2000304","volume":"2","author":"HP Makarenkova","year":"2009","unstructured":"Makarenkova, H. P. et al. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2, ra55 (2009).","journal-title":"Sci. Signal."},{"key":"469_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fgene.2019.00102","volume":"10","author":"A Zinkle","year":"2019","unstructured":"Zinkle, A. & Mohammadi, M. Structural biology of the FGF7 subfamily. Front. Genet. 10, 102 (2019).","journal-title":"Front. Genet."},{"key":"469_CR46","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2017.06.063","volume":"20","author":"Z Huang","year":"2017","unstructured":"Huang, Z. et al. Uncoupling the mitogenic and metabolic functions of FGF1 by tuning FGF1-FGF receptor dimer stability. Cell Rep. 20, 1717\u20131728 (2017).","journal-title":"Cell Rep."},{"key":"469_CR47","doi-asserted-by":"publisher","first-page":"872","DOI":"10.12688\/f1000research.14143.1","volume":"7","author":"A Zinkle","year":"2018","unstructured":"Zinkle, A. & Mohammadi, M. A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination. F1000Research 7, 872 (2018).","journal-title":"F1000Research"},{"key":"469_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0167-4781(95)00156-B","volume":"1264","author":"E Scotet","year":"1995","unstructured":"Scotet, E. & Houssaint, E. The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific. Biochim. Biophys. Acta 1264, 238\u2013242 (1995).","journal-title":"Biochim. Biophys. Acta"},{"key":"469_CR49","first-page":"5206","volume":"54","author":"B Murgue","year":"1994","unstructured":"Murgue, B., Tsunekawa, S., Rosenberg, I., de Beaumont, M. & Podolsky, D. K. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium. Cancer Res. 54, 5206\u20135211 (1994).","journal-title":"Cancer Res."},{"key":"469_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0092-8674(00)80851-X","volume":"101","author":"AN Plotnikov","year":"2000","unstructured":"Plotnikov, A. N., Hubbard, S. R., Schlessinger, J. & Mohammadi, M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101, 413\u2013424 (2000).","journal-title":"Cell"},{"key":"469_CR51","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1073\/pnas.0436500100","volume":"100","author":"BK Yeh","year":"2003","unstructured":"Yeh, B. K. et al. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc. Natl Acad. Sci. USA 100, 2266\u20132271 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gad.1365406","volume":"20","author":"SK Olsen","year":"2006","unstructured":"Olsen, S. K. et al. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 20, 185\u2013198 (2006).","journal-title":"Genes Dev."},{"key":"469_CR53","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.str.2017.06.016","volume":"25","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Regulation of receptor binding specificity of FGF9 by an autoinhibitory homodimerization. Structure 25, 1325\u20131336.e3 (2017).","journal-title":"Structure"},{"key":"469_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz, D. M. & Itoh, N. The fibroblast growth factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 4, 215\u2013266 (2015).","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"469_CR55","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1073\/pnas.0914157107","volume":"107","author":"JH Bae","year":"2010","unstructured":"Bae, J. H. et al. Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Proc. Natl Acad. Sci. USA 107, 2866\u20132871 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41589-019-0455-7","volume":"16","author":"Chen","year":"2020","unstructured":"Chen et al. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nat. Chem. Biol. 16, 267\u2013277 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"469_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(00)80131-2","volume":"86","author":"M Mohammadi","year":"1996","unstructured":"Mohammadi, M., Schlessinger, J. & Hubbard, S. R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86, 577\u2013587 (1996).","journal-title":"Cell"},{"key":"469_CR58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2007.06.028","volume":"27","author":"H Chen","year":"2007","unstructured":"Chen, H. et al. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. Mol. Cell 27, 717\u2013730 (2007).","journal-title":"Mol. Cell"},{"key":"469_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139\u2013149 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"469_CR60","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1128\/MCB.11.10.5068","volume":"11","author":"M Mohammadi","year":"1991","unstructured":"Mohammadi, M. et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol. Cell Biol. 11, 5068\u20135078 (1991).","journal-title":"Mol. Cell Biol."},{"key":"469_CR61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1242\/dev.114.1.233","volume":"114","author":"KG Peters","year":"1992","unstructured":"Peters, K. G., Werner, S., Chen, G. & Williams, L. T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 233\u2013243 (1992).","journal-title":"Development"},{"key":"469_CR62","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/cr0002801","volume":"101","author":"AC Newton","year":"2001","unstructured":"Newton, A. C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101, 2353\u20132364 (2001).","journal-title":"Chem. Rev."},{"key":"469_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrm2847","volume":"11","author":"C Rosse","year":"2010","unstructured":"Rosse, C. et al. PKC and the control of localized signal dynamics. Nat. Rev. Mol. Cell Biol. 11, 103\u2013112 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"469_CR64","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1021\/acs.biochem.5b00565","volume":"54","author":"TI Igumenova","year":"2015","unstructured":"Igumenova, T. I. Dynamics and membrane interactions of protein kinase C. Biochemistry 54, 4953\u20134968 (2015).","journal-title":"Biochemistry"},{"key":"469_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"N Turner","year":"2010","unstructured":"Turner, N. & Grose, R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116\u2013129 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"469_CR66","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1074\/jbc.M307330200","volume":"279","author":"EY Shin","year":"2004","unstructured":"Shin, E. Y. et al. Basic fibroblast growth factor stimulates activation of Rac1 through a p85 \u03b2PIX phosphorylation-dependent pathway. J. Biol. Chem. 279, 1994\u20132004 (2004).","journal-title":"J. Biol. Chem."},{"key":"469_CR67","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1167\/iovs.05-1223","volume":"47","author":"JG Lee","year":"2006","unstructured":"Lee, J. G. & Kay, E. P. FGF-2-induced wound healing in corneal endothelial cells requires Cdc42 activation and Rho inactivation through the phosphatidylinositol 3-kinase pathway. Invest. Ophthalmol. Vis. Sci. 47, 1376\u20131386 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"469_CR68","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1073\/pnas.94.7.2798","volume":"94","author":"J Schlessinger","year":"1997","unstructured":"Schlessinger, J. Phospholipase C\u03b3 activation and phosphoinositide hydrolysis are essential for embryonal development. Proc. Natl Acad. Sci. USA 94, 2798\u20132799 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR69","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.1074\/jbc.273.19.11650","volume":"273","author":"MV Ellis","year":"1998","unstructured":"Ellis, M. V. et al. Catalytic domain of phosphoinositide-specific phospholipase C (PLC). Mutational analysis of residues within the active site and hydrophobic ridge of PLC\u03b41. J. Biol. Chem. 273, 11650\u201311659 (1998).","journal-title":"J. Biol. Chem."},{"key":"469_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/364249a0","volume":"364","author":"W Kolch","year":"1993","unstructured":"Kolch, W. et al. Protein kinase C\u03b1 activates RAF-1 by direct phosphorylation. Nature 364, 249\u2013252 (1993).","journal-title":"Nature"},{"key":"469_CR71","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.str.2012.09.005","volume":"20","author":"TD Bunney","year":"2012","unstructured":"Bunney, T. D. et al. Structural and functional integration of the PLC\u03b3 interaction domains critical for regulatory mechanisms and signaling deregulation. Structure 20, 2062\u20132075 (2012).","journal-title":"Structure"},{"key":"469_CR72","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1021\/bi400433b","volume":"52","author":"N Hajicek","year":"2013","unstructured":"Hajicek, N., Charpentier, T. H., Rush, J. R., Harden, T. K. & Sondek, J. Autoinhibition and phosphorylation-induced activation of phospholipase C-\u03b3 isozymes. Biochemistry 52, 4810\u20134819 (2013).","journal-title":"Biochemistry"},{"key":"469_CR73","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1073\/pnas.0409590102","volume":"102","author":"B Poulin","year":"2005","unstructured":"Poulin, B., Sekiya, F. & Rhee, S. G. Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-\u03b31. Proc. Natl Acad. Sci. USA 102, 4276\u20134281 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR74","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molcel.2015.11.010","volume":"61","author":"Z Huang","year":"2016","unstructured":"Huang, Z. et al. Two FGF receptor kinase molecules act in concert to recruit and transphosphorylate phospholipase C\u03b3. Mol. Cell 61, 98\u2013110 (2016).","journal-title":"Mol. Cell"},{"key":"469_CR75","first-page":"721","volume":"13","author":"JK Wang","year":"1996","unstructured":"Wang, J. K., Xu, H., Li, H. C. & Goldfarb, M. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras. Oncogene 13, 721\u2013729 (1996).","journal-title":"Oncogene"},{"key":"469_CR76","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","volume":"89","author":"H Kouhara","year":"1997","unstructured":"Kouhara, H. et al. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway. Cell 89, 693\u2013702 (1997).","journal-title":"Cell"},{"key":"469_CR77","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1128\/MCB.18.7.3966","volume":"18","author":"YR Hadari","year":"1998","unstructured":"Hadari, Y. R., Kouhara, H., Lax, I. & Schlessinger, J. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol. Cell Biol. 18, 3966\u20133973 (1998).","journal-title":"Mol. Cell Biol."},{"key":"469_CR78","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1349-7006.2008.00840.x","volume":"99","author":"N Gotoh","year":"2008","unstructured":"Gotoh, N. Regulation of growth factor signaling by FRS2 family docking\/scaffold adaptor proteins. Cancer Sci. 99, 1319\u20131325 (2008).","journal-title":"Cancer Sci."},{"key":"469_CR79","doi-asserted-by":"publisher","first-page":"17987","DOI":"10.1074\/jbc.273.29.17987","volume":"273","author":"H Xu","year":"1998","unstructured":"Xu, H., Lee, K. W. & Goldfarb, M. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J. Biol. Chem. 273, 17987\u201317990 (1998).","journal-title":"J. Biol. Chem."},{"key":"469_CR80","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1128\/MCB.20.3.979-989.2000","volume":"20","author":"SH Ong","year":"2000","unstructured":"Ong, S. H. et al. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell Biol. 20, 979\u2013989 (2000).","journal-title":"Mol. Cell Biol."},{"key":"469_CR81","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1074\/jbc.M803998200","volume":"284","author":"JY Cha","year":"2009","unstructured":"Cha, J. Y., Maddileti, S., Mitin, N., Harden, T. K. & Der, C. J. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform. J. Biol. Chem. 284, 6227\u20136240 (2009).","journal-title":"J. Biol. Chem."},{"key":"469_CR82","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S1097-2765(05)00087-0","volume":"6","author":"C Dhalluin","year":"2000","unstructured":"Dhalluin, C. et al. Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors. Mol. Cell 6, 921\u2013929 (2000).","journal-title":"Mol. Cell"},{"key":"469_CR83","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.8493579","volume":"260","author":"P Chardin","year":"1993","unstructured":"Chardin, P. et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260, 1338\u20131343 (1993).","journal-title":"Science"},{"key":"469_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/363085a0","volume":"363","author":"N Li","year":"1993","unstructured":"Li, N. et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, 85\u201388 (1993).","journal-title":"Nature"},{"key":"469_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/1074-5521(95)90080-2","volume":"2","author":"JA Simon","year":"1995","unstructured":"Simon, J. A. & Schreiber, S. L. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions. Chem. Biol. 2, 53\u201360 (1995).","journal-title":"Chem. Biol."},{"key":"469_CR86","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1083\/jcb.149.7.1419","volume":"149","author":"U Schaeper","year":"2000","unstructured":"Schaeper, U. et al. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 149, 1419\u20131432 (2000).","journal-title":"J. Cell Biol."},{"key":"469_CR87","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1073\/pnas.111114298","volume":"98","author":"SH Ong","year":"2001","unstructured":"Ong, S. H. et al. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc. Natl Acad. Sci. USA 98, 6074\u20136079 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR88","doi-asserted-by":"publisher","first-page":"31536","DOI":"10.1074\/jbc.M003597200","volume":"275","author":"LS Lock","year":"2000","unstructured":"Lock, L. S., Royal, I., Naujokas, M. A. & Park, M. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J. Biol. Chem. 275, 31536\u201331545 (2000).","journal-title":"J. Biol. Chem."},{"key":"469_CR89","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1128\/MCB.24.13.5657-5666.2004","volume":"24","author":"B Lamothe","year":"2004","unstructured":"Lamothe, B. et al. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase\/Akt antiapoptotic pathway. Mol. Cell Biol. 24, 5657\u20135666 (2004).","journal-title":"Mol. Cell Biol."},{"key":"469_CR90","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1128\/MCB.20.4.1448-1459.2000","volume":"20","author":"GA Rodrigues","year":"2000","unstructured":"Rodrigues, G. A., Falasca, M., Zhang, Z., Ong, S. H. & Schlessinger, J. A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol. Cell Biol. 20, 1448\u20131459 (2000).","journal-title":"Mol. Cell Biol."},{"key":"469_CR91","doi-asserted-by":"publisher","first-page":"21138","DOI":"10.3390\/ijms160921138","volume":"16","author":"S Faes","year":"2015","unstructured":"Faes, S. & Dormond, O. PI3K and AKT: unfaithful partners in cancer. Int. J. Mol. Sci. 16, 21138\u201321152 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"469_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-7-13","volume":"7","author":"RB Birge","year":"2009","unstructured":"Birge, R. B., Kalodimos, C., Inagaki, F. & Tanaka, S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun. Signal. 7, 13 (2009).","journal-title":"Cell Commun. Signal."},{"key":"469_CR93","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1128\/MCB.01686-08","volume":"29","author":"JH Seo","year":"2009","unstructured":"Seo, J. H., Suenaga, A., Hatakeyama, M., Taiji, M. & Imamoto, A. Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Mol. Cell Biol. 29, 3076\u20133087 (2009).","journal-title":"Mol. Cell Biol."},{"key":"469_CR94","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/onc.2013.453","volume":"33","author":"TJ Park","year":"2014","unstructured":"Park, T. J. & Curran, T. Essential roles of Crk and CrkL in fibroblast structure and motility. Oncogene 33, 5121\u20135132 (2014).","journal-title":"Oncogene"},{"key":"469_CR95","doi-asserted-by":"publisher","first-page":"26273","DOI":"10.1074\/jbc.M116.764613","volume":"291","author":"T Park","year":"2016","unstructured":"Park, T., Koptyra, M. & Curran, T. Fibroblast growth requires CT10 regulator of kinase (Crk) and Crk-like (CrkL). J. Biol. Chem. 291, 26273\u201326290 (2016).","journal-title":"J. Biol. Chem."},{"key":"469_CR96","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32586","volume":"7","author":"TN Collins","year":"2018","unstructured":"Collins, T. N. et al. Crk proteins transduce FGF signaling to promote lens fiber cell elongation. eLife 7, e32586 (2018).","journal-title":"eLife"},{"key":"469_CR97","doi-asserted-by":"publisher","first-page":"18169","DOI":"10.1074\/jbc.M008870200","volume":"276","author":"S Kao","year":"2001","unstructured":"Kao, S., Jaiswal, R. K., Kolch, W. & Landreth, G. E. Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276, 18169\u201318177 (2001).","journal-title":"J. Biol. Chem."},{"key":"469_CR98","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/367040a0","volume":"367","author":"E Manser","year":"1994","unstructured":"Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. & Lim, L. A brain serine\/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40\u201346 (1994).","journal-title":"Nature"},{"key":"469_CR99","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1128\/MCB.21.19.6706-6717.2001","volume":"21","author":"O Zugasti","year":"2001","unstructured":"Zugasti, O. et al. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol. Cell Biol. 21, 6706\u20136717 (2001).","journal-title":"Mol. Cell Biol."},{"key":"469_CR100","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","volume":"8","author":"W Lu","year":"2001","unstructured":"Lu, W., Gong, D., Bar-Sagi, D. & Cole, P. A. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell 8, 759\u2013769 (2001).","journal-title":"Mol. Cell"},{"key":"469_CR101","doi-asserted-by":"publisher","first-page":"41677","DOI":"10.1074\/jbc.M306461200","volume":"278","author":"T Araki","year":"2003","unstructured":"Araki, T., Nawa, H. & Neel, B. G. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J. Biol. Chem. 278, 41677\u201341684 (2003).","journal-title":"J. Biol. Chem."},{"key":"469_CR102","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","volume":"20","author":"M Dance","year":"2008","unstructured":"Dance, M., Montagner, A., Salles, J. P., Yart, A. & Raynal, P. The molecular functions of Shp2 in the Ras\/mitogen-activated protein kinase (ERK1\/2) pathway. Cell Signal. 20, 453\u2013459 (2008).","journal-title":"Cell Signal."},{"key":"469_CR103","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ncb867","volume":"4","author":"H Hanafusa","year":"2002","unstructured":"Hanafusa, H., Torii, S., Yasunaga, T. & Nishida, E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras\/MAPK signalling pathway. Nat. Cell Biol. 4, 850\u2013858 (2002).","journal-title":"Nat. Cell Biol."},{"key":"469_CR104","doi-asserted-by":"publisher","first-page":"22992","DOI":"10.1074\/jbc.M312498200","volume":"279","author":"H Hanafusa","year":"2004","unstructured":"Hanafusa, H., Torii, S., Yasunaga, T., Matsumoto, K. & Nishida, E. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J. Biol. Chem. 279, 22992\u201322995 (2004).","journal-title":"J. Biol. Chem."},{"key":"469_CR105","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/bs.ctdb.2018.11.020","volume":"133","author":"DM Ornitz","year":"2019","unstructured":"Ornitz, D. M. & Marie, P. J. Fibroblast growth factors in skeletal development. Curr. Top. Dev. Biol. 133, 195\u2013234 (2019).","journal-title":"Curr. Top. Dev. Biol."},{"key":"469_CR106","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1002\/jcp.24083","volume":"227","author":"X Du","year":"2012","unstructured":"Du, X., Xie, Y., Xian, C. J. & Chen, L. Role of FGFs\/FGFRs in skeletal development and bone regeneration. J. Cell. Physiol. 227, 3731\u20133743 (2012).","journal-title":"J. Cell. Physiol."},{"key":"469_CR107","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng1194-269","volume":"8","author":"M Muenke","year":"1994","unstructured":"Muenke, M. et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat. Genet. 8, 269\u2013274 (1994).","journal-title":"Nat. Genet."},{"key":"469_CR108","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/427956","volume":"76","author":"KE White","year":"2005","unstructured":"White, K. E. et al. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am. J. Hum. Genet. 76, 361\u2013367 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng0295-165","volume":"9","author":"AO Wilkie","year":"1995","unstructured":"Wilkie, A. O. et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9, 165\u2013172 (1995).","journal-title":"Nat. Genet."},{"key":"469_CR110","first-page":"491","volume":"58","author":"GA Meyers","year":"1996","unstructured":"Meyers, G. A. et al. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am. J. Hum. Genet. 58, 491\u2013498 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR111","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/hmg\/4.7.1229","volume":"4","author":"WJ Park","year":"1995","unstructured":"Park, W. J. et al. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum. Mol. Genet. 4, 1229\u20131233 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR112","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000472215","volume":"4","author":"LJ Pulleyn","year":"1996","unstructured":"Pulleyn, L. J. et al. Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus. Eur. J. Hum. Genet. 4, 283\u2013291 (1996).","journal-title":"Eur. J. Hum. Genet."},{"key":"469_CR113","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ng0896-492","volume":"13","author":"KA Przylepa","year":"1996","unstructured":"Przylepa, K. A. et al. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat. Genet. 13, 492\u2013494 (1996).","journal-title":"Nat. Genet."},{"key":"469_CR114","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajhg.2012.02.005","volume":"90","author":"AE Merrill","year":"2012","unstructured":"Merrill, A. E. et al. Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. Am. J. Hum. Genet. 90, 550\u2013557 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR115","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.95.8.4567","volume":"95","author":"SC Robertson","year":"1998","unstructured":"Robertson, S. C. et al. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc. Natl Acad. Sci. USA 95, 4567\u20134572 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR116","first-page":"555","volume":"60","author":"M Muenke","year":"1997","unstructured":"Muenke, M. et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. 60, 555\u2013564 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR117","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng0395-321","volume":"9","author":"PL Tavormina","year":"1995","unstructured":"Tavormina, P. L. et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9, 321\u2013328 (1995).","journal-title":"Nat. Genet."},{"key":"469_CR118","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/01.prs.0000479978.75545.ee","volume":"137","author":"X Ye","year":"2016","unstructured":"Ye, X. et al. Mutation screening of candidate genes in patients with nonsyndromic sagittal craniosynostosis. Plast. Reconstr. Surg. 137, 952\u2013961 (2016).","journal-title":"Plast. Reconstr. Surg."},{"key":"469_CR119","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1002\/ajmg.a.34199","volume":"155A","author":"E Barroso","year":"2011","unstructured":"Barroso, E. et al. Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr. Am. J. Med. Genet. A 155A, 3050\u20133053 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"469_CR120","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","volume":"5","author":"F Rousseau","year":"1996","unstructured":"Rousseau, F. et al. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet. 5, 509\u2013512 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR121","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","volume":"78","author":"R Shiang","year":"1994","unstructured":"Shiang, R. et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335\u2013342 (1994).","journal-title":"Cell"},{"key":"469_CR122","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng0795-357","volume":"10","author":"GA Bellus","year":"1995","unstructured":"Bellus, G. A. et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10, 357\u2013359 (1995).","journal-title":"Nat. Genet."},{"key":"469_CR123","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/jmg.33.9.744","volume":"33","author":"D Wilkes","year":"1996","unstructured":"Wilkes, D. et al. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J. Med. Genet. 33, 744\u2013748 (1996).","journal-title":"J. Med. Genet."},{"key":"469_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10262","volume":"7","author":"S Sarabipour","year":"2016","unstructured":"Sarabipour, S. & Hristova, K. Mechanism of FGF receptor dimerization and activation. Nat. Commun. 7, 10262 (2016).","journal-title":"Nat. Commun."},{"key":"469_CR125","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jmb.2015.02.013","volume":"427","author":"S Sarabipour","year":"2015","unstructured":"Sarabipour, S. & Hristova, K. FGFR3 unliganded dimer stabilization by the juxtamembrane domain. J. Mol. Biol. 427, 1705\u20131714 (2015).","journal-title":"J. Mol. Biol."},{"key":"469_CR126","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jmb.2005.11.077","volume":"356","author":"E Li","year":"2006","unstructured":"Li, E., You, M. & Hristova, K. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation. J. Mol. Biol. 356, 600\u2013612 (2006).","journal-title":"J. Mol. Biol."},{"key":"469_CR127","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1093\/hmg\/ddu004","volume":"23","author":"F Di Rocco","year":"2014","unstructured":"Di Rocco, F. et al. FGFR3 mutation causes abnormal membranous ossification in achondroplasia. Hum. Mol. Genet. 23, 2914\u20132925 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR128","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/713803609","volume":"49","author":"K Kannan","year":"2000","unstructured":"Kannan, K. & Givol, D. FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models. IUBMB Life 49, 197\u2013205 (2000).","journal-title":"IUBMB Life"},{"key":"469_CR129","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng0696-233","volume":"13","author":"MC Naski","year":"1996","unstructured":"Naski, M. C., Wang, Q., Xu, J. & Ornitz, D. M. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233\u2013237 (1996).","journal-title":"Nat. Genet."},{"key":"469_CR130","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/SCS.0b013e31824db8bb","volume":"23","author":"NB Agochukwu","year":"2012","unstructured":"Agochukwu, N. B., Solomon, B. D., Doherty, E. S. & Muenke, M. Palatal and oral manifestations of Muenke syndrome (FGFR3-related craniosynostosis). J. Craniofac. Surg. 23, 664\u2013668 (2012).","journal-title":"J. Craniofac. Surg."},{"key":"469_CR131","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.gene.2013.09.120","volume":"534","author":"L Grillo","year":"2014","unstructured":"Grillo, L. et al. Increased FGF3 and FGF4 gene dosage is a risk factor for craniosynostosis. Gene 534, 435\u2013439 (2014).","journal-title":"Gene"},{"key":"469_CR132","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000152034","volume":"2","author":"JP Hardelin","year":"2008","unstructured":"Hardelin, J. P. & Dode, C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex. Dev. 2, 181\u2013193 (2008).","journal-title":"Sex. Dev."},{"key":"469_CR133","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1210\/jc.2004-2238","volume":"90","author":"T Larsson","year":"2005","unstructured":"Larsson, T. et al. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J. Clin. Endocrinol. Metab. 90, 2424\u20132427 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"469_CR134","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/humu.23292","volume":"38","author":"M Rodriguez-Zabala","year":"2017","unstructured":"Rodriguez-Zabala, M. et al. FGF9 mutation causes craniosynostosis along with multiple synostoses. Hum. Mutat. 38, 1471\u20131476 (2017).","journal-title":"Hum. Mutat."},{"key":"469_CR135","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ng1757","volume":"38","author":"E Rohmann","year":"2006","unstructured":"Rohmann, E. et al. Mutations in different components of FGF signaling in LADD syndrome. Nat. Genet. 38, 414\u2013417 (2006).","journal-title":"Nat. Genet."},{"key":"469_CR136","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/hmg\/ddx029","volume":"26","author":"L Tang","year":"2017","unstructured":"Tang, L. et al. A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome. Hum. Mol. Genet. 26, 1280\u20131293 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR137","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/510920","volume":"80","author":"M Tekin","year":"2007","unstructured":"Tekin, M. et al. Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am. J. Hum. Genet. 80, 338\u2013344 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR138","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajhg.2009.06.007","volume":"85","author":"XL Wu","year":"2009","unstructured":"Wu, X. L. et al. Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene. Am. J. Hum. Genet. 85, 53\u201363 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"469_CR139","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","volume":"118","author":"I Chefetz","year":"2005","unstructured":"Chefetz, I. et al. A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification. Hum. Genet. 118, 261\u2013266 (2005).","journal-title":"Hum. Genet."},{"key":"469_CR140","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya, K. et al. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J. Clin. Endocrinol. Metab. 90, 5523\u20135527 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"469_CR141","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gene.2014.03.052","volume":"542","author":"F Abbasi","year":"2014","unstructured":"Abbasi, F. et al. A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS). Gene 542, 269\u2013271 (2014).","journal-title":"Gene"},{"key":"469_CR142","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26, 345\u2013348 (2000).","journal-title":"Nat. Genet."},{"key":"469_CR143","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White, K. E. et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 60, 2079\u20132086 (2001).","journal-title":"Kidney Int."},{"key":"469_CR144","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","volume":"28","author":"M Gribaa","year":"2010","unstructured":"Gribaa, M. et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J. Bone Miner. Metab. 28, 111\u2013115 (2010).","journal-title":"J. Bone Miner. Metab."},{"key":"469_CR145","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada, T. et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143, 3179\u20133182 (2002).","journal-title":"Endocrinology"},{"key":"469_CR146","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","volume":"16","author":"DM Ornitz","year":"2005","unstructured":"Ornitz, D. M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16, 205\u2013213 (2005).","journal-title":"Cytokine Growth Factor Rev."},{"key":"469_CR147","doi-asserted-by":"publisher","first-page":"a008334","DOI":"10.1101\/cshperspect.a008334","volume":"5","author":"F Long","year":"2013","unstructured":"Long, F. & Ornitz, D. M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 5, a008334 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"469_CR148","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1387\/ijdb.092887cs","volume":"54","author":"CJ Sheeba","year":"2010","unstructured":"Sheeba, C. J., Andrade, R. P., Duprez, D. & Palmeirim, I. Comprehensive analysis of fibroblast growth factor receptor expression patterns during chick forelimb development. Int. J. Dev. Biol. 54, 1517\u20131526 (2010).","journal-title":"Int. J. Dev. Biol."},{"key":"469_CR149","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1242\/dev.113.4.1419","volume":"113","author":"A Orr-Urtreger","year":"1991","unstructured":"Orr-Urtreger, A., Givol, D., Yayon, A., Yarden, Y. & Lonai, P. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 113, 1419\u20131434 (1991).","journal-title":"Development"},{"key":"469_CR150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1242\/dev.127.5.989","volume":"127","author":"AM Moon","year":"2000","unstructured":"Moon, A. M., Boulet, A. M. & Capecchi, M. R. Normal limb development in conditional mutants of Fgf4. Development 127, 989\u2013996 (2000).","journal-title":"Development"},{"key":"469_CR151","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature06876","volume":"453","author":"FV Mariani","year":"2008","unstructured":"Mariani, F. V., Ahn, C. P. & Martin, G. R. Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. Nature 453, 401\u2013405 (2008).","journal-title":"Nature"},{"key":"469_CR152","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fgene.2018.00705","volume":"9","author":"L Jin","year":"2019","unstructured":"Jin, L., Wu, J., Bellusci, S. & Zhang, J.-S. Fibroblast growth factor 10 and vertebrate limb development. Front. Genet. 9, 705 (2019).","journal-title":"Front. Genet."},{"key":"469_CR153","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","volume":"77","author":"AL Delezoide","year":"1998","unstructured":"Delezoide, A. L. et al. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev. 77, 19\u201330 (1998).","journal-title":"Mech. Dev."},{"key":"469_CR154","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1242\/dev.129.16.3783","volume":"129","author":"VP Eswarakumar","year":"2002","unstructured":"Eswarakumar, V. P. et al. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129, 3783\u20133793 (2002).","journal-title":"Development"},{"key":"469_CR155","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ydbio.2006.05.031","volume":"296","author":"AL Jacob","year":"2006","unstructured":"Jacob, A. L., Smith, C., Partanen, J. & Ornitz, D. M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. 296, 315\u2013328 (2006).","journal-title":"Dev. Biol."},{"key":"469_CR156","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bone.2006.10.013","volume":"40","author":"JE Lazarus","year":"2007","unstructured":"Lazarus, J. E., Hegde, A., Andrade, A. C., Nilsson, O. & Baron, J. Fibroblast growth factor expression in the postnatal growth plate. Bone 40, 577\u2013586 (2007).","journal-title":"Bone"},{"key":"469_CR157","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/j.1460-2075.1991.tb07654.x","volume":"10","author":"J Partanen","year":"1991","unstructured":"Partanen, J. et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 10, 1347\u20131354 (1991).","journal-title":"EMBO J."},{"key":"469_CR158","first-page":"519","volume":"46","author":"S Cool","year":"2002","unstructured":"Cool, S., Jackson, R., Pincus, P., Dickinson, I. & Nurcombe, V. Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. Int. J. Dev. Biol. 46, 519\u2013523 (2002).","journal-title":"Int. J. Dev. Biol."},{"key":"469_CR159","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddv019","volume":"24","author":"MR Karolak","year":"2015","unstructured":"Karolak, M. R., Yang, X. & Elefteriou, F. FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation. Hum. Mol. Genet. 24, 2552\u20132564 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR160","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ydbio.2007.04.048","volume":"307","author":"IH Hung","year":"2007","unstructured":"Hung, I. H., Yu, K., Lavine, K. J. & Ornitz, D. M. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev. Biol. 307, 300\u2013313 (2007).","journal-title":"Dev. Biol."},{"key":"469_CR161","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1242\/dev.131722","volume":"143","author":"K Karuppaiah","year":"2016","unstructured":"Karuppaiah, K. et al. FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth. Development 143, 1811\u20131822 (2016).","journal-title":"Development"},{"key":"469_CR162","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1101\/gad.965702","volume":"16","author":"N Ohbayashi","year":"2002","unstructured":"Ohbayashi, N. et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870\u2013879 (2002).","journal-title":"Genes Dev."},{"key":"469_CR163","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11914-014-0247-7","volume":"13","author":"L Longobardi","year":"2015","unstructured":"Longobardi, L. et al. Synovial joints: from development to homeostasis. Curr. Osteoporos. Rep. 13, 41\u201351 (2015).","journal-title":"Curr. Osteoporos. Rep."},{"key":"469_CR164","first-page":"5","volume":"103","author":"I Lovinescu","year":"2003","unstructured":"Lovinescu, I., Koyama, E. & Pacifici, M. Roles of FGF-10 on the development of diathrodial limb joints. Penn Dent. J. 103, 5\u20139 (2003).","journal-title":"Penn Dent. J."},{"key":"469_CR165","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/ar3441","volume":"13","author":"D Yan","year":"2011","unstructured":"Yan, D. et al. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res. Ther. 13, R130 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"469_CR166","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/CJP.CJP_23_19","volume":"62","author":"TM Chen","year":"2019","unstructured":"Chen, T. M., Chen, Y. H., Sun, H. S. & Tsai, S. J. Fibroblast growth factors: potential novel targets for regenerative therapy of osteoarthritis. Chin. J. Physiol. 62, 2\u201310 (2019).","journal-title":"Chin. J. Physiol."},{"key":"469_CR167","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/dvdy.85","volume":"248","author":"AS Hagan","year":"2019","unstructured":"Hagan, A. S. et al. Generation and validation of novel conditional flox and inducible Cre alleles targeting fibroblast growth factor 18 (Fgf18). Dev. Dyn. 248, 882\u2013893 (2019).","journal-title":"Dev. Dyn."},{"key":"469_CR168","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2006.06.033","volume":"375","author":"CJ Malemud","year":"2007","unstructured":"Malemud, C. J. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin. Chim. Acta 375, 10\u201319 (2007).","journal-title":"Clin. Chim. Acta"},{"key":"469_CR169","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376\u2013387 (2015).","journal-title":"Lancet"},{"key":"469_CR170","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser, R. F., Collins, J. A. & Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412\u2013420 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR171","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.joca.2005.02.003","volume":"13","author":"S Daouti","year":"2005","unstructured":"Daouti, S. et al. Development of comprehensive functional genomic screens to identify novel mediators of osteoarthritis. Osteoarthr. Cartilage 13, 508\u2013518 (2005).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR172","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1074\/jbc.M609040200","volume":"282","author":"HJ Im","year":"2007","unstructured":"Im, H. J. et al. Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase C\u03b4 pathways in human adult articular chondrocytes. J. Biol. Chem. 282, 11110\u201311121 (2007).","journal-title":"J. Biol. Chem."},{"key":"469_CR173","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1002\/art.34645","volume":"64","author":"T Weng","year":"2012","unstructured":"Weng, T. et al. Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice. Arthritis Rheum. 64, 3982\u20133992 (2012).","journal-title":"Arthritis Rheum."},{"key":"469_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/srep24042","volume":"6","author":"W Xu","year":"2016","unstructured":"Xu, W. et al. A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis. Sci. Rep. 6, 24042 (2016).","journal-title":"Sci. Rep."},{"key":"469_CR175","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/art.39739","volume":"68","author":"J Tang","year":"2016","unstructured":"Tang, J. et al. Fibroblast growth factor receptor 3 inhibits osteoarthritis progression in the knee joints of adult mice. Arthritis Rheumatol. 68, 2432\u20132443 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"469_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/srep24039","volume":"6","author":"S Zhou","year":"2016","unstructured":"Zhou, S. et al. Conditional deletion of Fgfr3 in chondrocytes leads to osteoarthritis-like defects in temporomandibular joint of adult mice. Sci. Rep. 6, 24039 (2016).","journal-title":"Sci. Rep."},{"key":"469_CR177","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/annrheumdis-2019-215696","volume":"79","author":"L Kuang","year":"2020","unstructured":"Kuang, L. et al. FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice. Ann. Rheum. Dis. 79, 112\u2013122 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"469_CR178","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1093\/hmg\/ddv419","volume":"25","author":"KA Klag","year":"2016","unstructured":"Klag, K. A. & Horton, W. A. Advances in treatment of achondroplasia and osteoarthritis. Hum. Mol. Genet. 25, R2\u2013R8 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"469_CR179","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.joca.2018.05.009","volume":"26","author":"K Kisand","year":"2018","unstructured":"Kisand, K., Tamm, A. E., Lintrop, M. & Tamm, A. O. New insights into the natural course of knee osteoarthritis: early regulation of cytokines and growth factors, with emphasis on sex-dependent angiogenesis and tissue remodeling. A pilot study. Osteoarthr. Cartilage 26, 1045\u20131054 (2018).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR180","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/jcp.21317","volume":"215","author":"HJ Im","year":"2008","unstructured":"Im, H. J. et al. Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J. Cell. Physiol. 215, 452\u2013463 (2008).","journal-title":"J. Cell. Physiol."},{"key":"469_CR181","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.joca.2007.01.021","volume":"15","author":"TL Vincent","year":"2007","unstructured":"Vincent, T. L., McLean, C. J., Full, L. E., Peston, D. & Saklatvala, J. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthr. Cartilage 15, 752\u2013763 (2007).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR182","doi-asserted-by":"publisher","first-page":"31409","DOI":"10.1074\/jbc.M706508200","volume":"282","author":"P Muddasani","year":"2007","unstructured":"Muddasani, P., Norman, J. C., Ellman, M., van Wijnen, A. J. & Im, H. J. Basic fibroblast growth factor activates the MAPK and NF\u03baB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J. Biol. Chem. 282, 31409\u201331421 (2007).","journal-title":"J. Biol. Chem."},{"key":"469_CR183","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/03009742.2014.1000372","volume":"44","author":"E Nummenmaa","year":"2015","unstructured":"Nummenmaa, E., Hamalainen, M., Moilanen, T., Vuolteenaho, K. & Moilanen, E. Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes. Scand. J. Rheumatol. 44, 321\u2013330 (2015).","journal-title":"Scand. J. Rheumatol."},{"key":"469_CR184","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/art.38039","volume":"65","author":"KW Chong","year":"2013","unstructured":"Chong, K. W. et al. Fibroblast growth factor 2 drives changes in gene expression following injury to murine cartilage in vitro and in vivo. Arthritis Rheum. 65, 2346\u20132355 (2013).","journal-title":"Arthritis Rheum."},{"key":"469_CR185","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1002\/art.24025","volume":"58","author":"Y Sawaji","year":"2008","unstructured":"Sawaji, Y., Hynes, J., Vincent, T. & Saklatvala, J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum. 58, 3498\u20133509 (2008).","journal-title":"Arthritis Rheum."},{"key":"469_CR186","first-page":"2447","volume":"22","author":"ZF Tang","year":"2018","unstructured":"Tang, Z. F. & Li, H. Y. Effects of fibroblast growth factors 2 and low intensity pulsed ultrasound on the repair of knee articular cartilage in rabbits. Eur. Rev. Med. Pharmacol. Sci. 22, 2447\u20132453 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"469_CR187","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0006-291X(88)80887-8","volume":"156","author":"P Cuevas","year":"1988","unstructured":"Cuevas, P., Burgos, J. & Baird, A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem. Biophys. Res. Commun. 156, 611\u2013618 (1988).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"469_CR188","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/art.24654","volume":"60","author":"SL Chia","year":"2009","unstructured":"Chia, S. L. et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60, 2019\u20132027 (2009).","journal-title":"Arthritis Rheum."},{"key":"469_CR189","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1002\/jcp.27230","volume":"234","author":"PM Burt","year":"2019","unstructured":"Burt, P. M., Xiao, L., Doetschman, T. & Hurley, M. M. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection. J. Cell. Physiol. 234, 4418\u20134431 (2019).","journal-title":"J. Cell. Physiol."},{"key":"469_CR190","doi-asserted-by":"publisher","first-page":"11191","DOI":"10.4238\/2015.September.22.13","volume":"14","author":"R Li","year":"2015","unstructured":"Li, R. et al. Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis. Genet. Mol. Res. 14, 11191\u201311199 (2015).","journal-title":"Genet. Mol. Res."},{"key":"469_CR191","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12079-017-0384-8","volume":"11","author":"A El-Seoudi","year":"2017","unstructured":"El-Seoudi, A. et al. Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis. J. Cell Commun. Signal. 11, 255\u2013263 (2017).","journal-title":"J. Cell Commun. Signal."},{"key":"469_CR192","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar2474","volume":"10","author":"M Uchii","year":"2008","unstructured":"Uchii, M. et al. Role of fibroblast growth factor 8 (FGF8) in animal models of osteoarthritis. Arthritis Res. Ther. 10, R90 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"469_CR193","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1172\/JCI80205","volume":"126","author":"JS Rockel","year":"2016","unstructured":"Rockel, J. S. et al. Hedgehog inhibits \u03b2-catenin activity in synovial joint development and osteoarthritis. J. Clin. Invest. 126, 1649\u20131663 (2016).","journal-title":"J. Clin. Invest."},{"key":"469_CR194","doi-asserted-by":"publisher","first-page":"10192","DOI":"10.1074\/jbc.M113.524090","volume":"289","author":"Y Mori","year":"2014","unstructured":"Mori, Y. et al. Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling. J. Biol. Chem. 289, 10192\u201310200 (2014).","journal-title":"J. Biol. Chem."},{"key":"469_CR195","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1053\/joca.2002.0514","volume":"10","author":"JL Ellsworth","year":"2002","unstructured":"Ellsworth, J. L. et al. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthr. Cartilage 10, 308\u2013320 (2002).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR196","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","volume":"13","author":"EE Moore","year":"2005","unstructured":"Moore, E. E. et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthr. Cartilage 13, 623\u2013631 (2005).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR197","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.joca.2016.07.005","volume":"24","author":"S Zhou","year":"2016","unstructured":"Zhou, S. et al. Exogenous fibroblast growth factor 9 attenuates cartilage degradation and aggravates osteophyte formation in post-traumatic osteoarthritis. Osteoarthr. Cartilage 24, 2181\u20132192 (2016).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-19","volume":"11","author":"Y Sun","year":"2010","unstructured":"Sun, Y. et al. Analysis of meniscal degeneration and meniscal gene expression. BMC Musculoskelet. Disord. 11, 19 (2010).","journal-title":"BMC Musculoskelet. Disord."},{"key":"469_CR199","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00365513.2014.992942","volume":"75","author":"ZC Li","year":"2015","unstructured":"Li, Z. C. et al. Fibroblast growth factor-21 concentration in serum and synovial fluid is associated with radiographic bone loss of knee osteoarthritis. Scand. J. Clin. Lab. Invest. 75, 121\u2013125 (2015).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"469_CR200","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.joca.2016.06.003","volume":"24","author":"A Bianchi","year":"2016","unstructured":"Bianchi, A. et al. Fibroblast growth factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner. Osteoarthr. Cartilage 24, 1961\u20131969 (2016).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR201","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/en.2018-00184","volume":"159","author":"P Meo Burt","year":"2018","unstructured":"Meo Burt, P., Xiao, L. & Hurley, M. M. FGF23 regulates Wnt\/\u03b2-catenin signaling-mediated osteoarthritis in mice overexpressing high-molecular-weight FGF2. Endocrinology 159, 2386\u20132396 (2018).","journal-title":"Endocrinology"},{"key":"469_CR202","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/ten.tea.2010.0277","volume":"17","author":"JH Kim","year":"2011","unstructured":"Kim, J. H., Lee, M. C., Seong, S. C., Park, K. H. & Lee, S. Enhanced proliferation and chondrogenic differentiation of human synovium-derived stem cells expanded with basic fibroblast growth factor. Tissue Eng. Part A 17, 991\u20131002 (2011).","journal-title":"Tissue Eng. Part A"},{"key":"469_CR203","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/ten.tea.2010.0339","volume":"17","author":"J Li","year":"2011","unstructured":"Li, J. & Pei, M. Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering. Tissue Eng. Part A 17, 703\u2013712 (2011).","journal-title":"Tissue Eng. Part A"},{"key":"469_CR204","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/ten.tea.2018.0133","volume":"25","author":"X Chen","year":"2018","unstructured":"Chen, X. et al. Integration capacity of human induced pluripotent stem cell-derived cartilage. Tissue Eng. Part A 25, 437\u2013445 (2018).","journal-title":"Tissue Eng. Part A"},{"key":"469_CR205","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.joca.2017.08.004","volume":"25","author":"A Gigout","year":"2017","unstructured":"Gigout, A. et al. Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix. Osteoarthr. Cartilage 25, 1858\u20131867 (2017).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR206","doi-asserted-by":"publisher","first-page":"23","DOI":"10.22203\/eCM.v038a03","volume":"38","author":"GR Meloni","year":"2019","unstructured":"Meloni, G. R. et al. Recombinant human FGF18 preserves depth-dependent mechanical inhomogeneity in articular cartilage. Eur. Cell Mater. 38, 23\u201334 (2019).","journal-title":"Eur. Cell Mater."},{"key":"469_CR207","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/jor.24048","volume":"36","author":"ML Sennett","year":"2018","unstructured":"Sennett, M. L. et al. Sprifermin treatment enhances cartilage integration in an in vitro repair model. J. Orthop. Res. 36, 2648\u20132656 (2018).","journal-title":"J. Orthop. Res."},{"key":"469_CR208","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jor.22622","volume":"32","author":"L Barr","year":"2014","unstructured":"Barr, L., Getgood, A., Guehring, H., Rushton, N. & Henson, F. M. The effect of recombinant human fibroblast growth factor-18 on articular cartilage following single impact load. J. Orthop. Res. 32, 923\u2013927 (2014).","journal-title":"J. Orthop. Res."},{"key":"469_CR209","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.phrs.2018.09.026","volume":"139","author":"X Yao","year":"2019","unstructured":"Yao, X. et al. Fibroblast growth factor 18 exerts anti-osteoarthritic effects through PI3K-AKT signaling and mitochondrial fusion and fission. Pharmacol. Res. 139, 314\u2013324 (2019).","journal-title":"Pharmacol. Res."},{"key":"469_CR210","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jor.22882","volume":"33","author":"D Howard","year":"2015","unstructured":"Howard, D., Wardale, J., Guehring, H. & Henson, F. Delivering rhFGF-18 via a bilayer collagen membrane to enhance microfracture treatment of chondral defects in a large animal model. J. Orthop. Res. 33, 1120\u20131127 (2015).","journal-title":"J. Orthop. Res."},{"key":"469_CR211","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jor.22580","volume":"32","author":"J Power","year":"2014","unstructured":"Power, J., Hernandez, P., Guehring, H., Getgood, A. & Henson, F. Intra-articular injection of rhFGF-18 improves the healing in microfracture treated chondral defects in an ovine model. J. Orthop. Res. 32, 669\u2013676 (2014).","journal-title":"J. Orthop. Res."},{"key":"469_CR212","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1002\/art.39265","volume":"67","author":"F Eckstein","year":"2015","unstructured":"Eckstein, F., Wirth, W., Guermazi, A., Maschek, S. & Aydemir, A. Brief report: intraarticular sprifermin not only increases cartilage thickness, but also reduces cartilage loss: location-independent post hoc analysis using magnetic resonance imaging. Arthritis Rheumatol. 67, 2916\u20132922 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"469_CR213","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.38614","volume":"66","author":"LS Lohmander","year":"2014","unstructured":"Lohmander, L. S. et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 66, 1820\u20131831 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"469_CR214","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2019.14735","volume":"322","author":"MC Hochberg","year":"2019","unstructured":"Hochberg, M. C. et al. Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA 322, 1360\u20131370 (2019).","journal-title":"JAMA"},{"key":"469_CR215","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/1574888X1130800063","volume":"8","author":"A Sanghani","year":"2013","unstructured":"Sanghani, A., Chimutengwende-Gordon, M., Adesida, A. & Khan, W. Applications of stem cell therapy for physeal injuries. Curr. Stem Cell Res. Ther. 8, 451\u2013455 (2013).","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"469_CR216","doi-asserted-by":"publisher","first-page":"T45","DOI":"10.1530\/JME-14-0062","volume":"53","author":"R Chung","year":"2014","unstructured":"Chung, R. & Xian, C. J. Recent research on the growth plate: mechanisms for growth plate injury repair and potential cell-based therapies for regeneration. J. Mol. Endocrinol. 53, T45\u2013T61 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"469_CR217","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.joca.2005.02.007","volume":"13","author":"FM Henson","year":"2005","unstructured":"Henson, F. M., Bowe, E. A. & Davies, M. E. Promotion of the intrinsic damage-repair response in articular cartilage by fibroblastic growth factor-2. Osteoarthr. Cartilage 13, 537\u2013544 (2005).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR218","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/gt.2009.91","volume":"16","author":"M Cucchiarini","year":"2009","unstructured":"Cucchiarini, M., Schetting, S., Terwilliger, E. F., Kohn, D. & Madry, H. rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and \u03b1-SMA expression in human meniscal lesions. Gene Ther. 16, 1363\u20131372 (2009).","journal-title":"Gene Ther."},{"key":"469_CR219","doi-asserted-by":"publisher","first-page":"dmm.031526","DOI":"10.1242\/dmm.031526","volume":"11","author":"L Schmidt","year":"2018","unstructured":"Schmidt, L., Taiyab, A., Melvin, V. S., Jones, K. L. & Williams, T. Increased FGF8 signaling promotes chondrogenic rather than osteogenic development in the embryonic skull. Dis. Model. Mech. 11, dmm.031526 (2018).","journal-title":"Dis. Model. Mech."},{"key":"469_CR220","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1016\/j.biomaterials.2012.07.020","volume":"33","author":"J Dai","year":"2012","unstructured":"Dai, J. et al. The effect of co-culturing costal chondrocytes and dental pulp stem cells combined with exogenous FGF9 protein on chondrogenesis and ossification in engineered cartilage. Biomaterials 33, 7699\u20137711 (2012).","journal-title":"Biomaterials"},{"key":"469_CR221","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.joca.2018.08.012","volume":"26","author":"Q Tan","year":"2018","unstructured":"Tan, Q. et al. A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult mice. Osteoarthr. Cartilage 26, 1733\u20131743 (2018).","journal-title":"Osteoarthr. Cartilage"},{"key":"469_CR222","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrrheum.2017.50","volume":"13","author":"A Mobasheri","year":"2017","unstructured":"Mobasheri, A. et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 13, 302\u2013311 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR223","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0309-1651(89)90148-3","volume":"13","author":"AM Makower","year":"1989","unstructured":"Makower, A. M., Wroblewski, J. & Pawlowski, A. Effects of IGF-I, rGH, FGF, EGF and NCS on DNA-synthesis, cell proliferation and morphology of chondrocytes isolated from rat rib growth cartilage. Cell Biol. Int. Rep. 13, 259\u2013270 (1989).","journal-title":"Cell Biol. Int. Rep."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0469-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:58:46Z","timestamp":1629143926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-0469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":223,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-0469-2","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"2 July 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}